4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone has been researched along with nystatin a1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, J; Marcus, DC; Shen, Z; Sunose, H | 1 |
1 other study(ies) available for 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and nystatin a1
Article | Year |
---|---|
cAMP increases apical IsK channel current and K+ secretion in vestibular dark cells.
Topics: 1-Methyl-3-isobutylxanthine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Bucladesine; Cell Membrane; Cyclic AMP; Cytosol; Electric Conductivity; Epithelial Cells; Epithelium; Gerbillinae; In Vitro Techniques; Nystatin; Patch-Clamp Techniques; Phosphodiesterase Inhibitors; Potassium; Potassium Channels; Potassium Channels, Voltage-Gated; Vestibule, Labyrinth | 1997 |